Phenanthrene derivatives from Appendicula reflexa as new CDK1/cyclin B inhibitors

Phytochemistry Letters

Volumn 5, Issue 4, 2012, Pages 814-818

  Apel, Cécile ^a   Dumontet, Vincent ^a   Lozach, Olivier ^b   Meijer, Laurent ^b,c   Guéritte, Françoise ^a   Litaudon, Marc ^a  

^a INSTITUT DE CHIMIE DES SUBSTANCES NATURELLES   (France)

^b STATION BIOLOGIQUE   (France)

^c Centre de Perharidy   (France)

Author keywords

Appendicula reflexa; Cyclin dependent kinase; Orchidaceae; Phenanthrene

Indexed keywords

3,4,6 TRIMETHOXYPHENANTHRENE 2,7 DIOL; 3,4,6,7 TETRAMETHOXYPHENANTHRENE 2,8 DIOL; 6 METHOXYCOELONIN; BLESTRIN E; COELONIN; CYCLIN B; CYCLIN DEPENDENT KINASE 1; CYTOTOXIC AGENT; NUDOL; PHENANTHRENE DERIVATIVE; UNCLASSIFIED DRUG;

APPENDICULA REFLEXA; ARTICLE; CELL STRAIN K 562; CELL STRAIN KB; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; ORCHIDACEAE; PRIORITY JOURNAL;

APPENDICULA; ORCHIDACEAE;

EID: 84869495625     PISSN: 18743900     EISSN: 18767486     Source Type: Journal    
DOI: 10.1016/j.phytol.2012.09.008     Document Type: Article

References (24)

1. L. Bai, M. Yamaki, K. Inoue, and S. Takagi Blestrin A and B, bis(dihydrophenanthrene)ethers from Bletilla striata Phytochemistry 29 1990 1259 1260
2. S.R. Bhandari, A.H. Kapadi, P.L. Majumder, M. Joardar, and J.N. Shoolery Nudol, a phenanthrene of the orchids Eulophia nuda, Eria carinata and Eria stricta Phytochemistry 24 1985 801 804
3. H. Galons, N. Oumata, and L. Meijer Cyclin-dependent kinase inhibitors: a survey of recent patent literature Expert Opin. Ther. Patents 20 2009 377 404
4. R.M.P. Gutiérrez Orchids: a review of uses in traditional medicine, its phytochemistry and pharmacology J. Med. Plant Res. 4 2010 592 638
5. J.W. Harper, and P.D. Adams Cyclin-dependent kinases Chem. Rev. 101 2001 2511 2526 (Pubitemid 35373032)
6. R.K. Juneja, S.C. Sharma, and J.S. Tandon Two substituted bibenzyls and a dihydrophenanthrene from Cymbidium aloifolium Phytochemistry 26 1987 1123 1125
7. M. Knockaert, P. Greengard, and L. Meijer Pharmacological inhibitors of cyclin-dependent kinases Trends Pharmacol. Sci. 23 2002 417 425 (Pubitemid 35247771)
8. A. Kovács, A. Vasa, and J. Hohmann Natural phenanthrenes and their biological activity Phytochemistry 69 2008 1084 1110
9. C. Kunick, C. Schultz, T. Lemcke, D.W. Zaharevitz, R. Gussio, R.K. Jalluri, E.A. Sausville, M. Leost, and L. Meijer 2-Substituted paullones: CDK1/cyclin B-inhibiting property and in vitro antiproliferative activity Bioorg. Med. Chem. Lett. 10 2000 567 569 (Pubitemid 30162462)
10. S. Leclerc, M. Garnier, R. Hoessel, D. Marko, J.A. Bibb, G.L. Snyder, P. Greengard, J. Biernat, E.-M. Mandelkow, G. Eisenbrand, and L. Meijer Indirubins inhibit glycogen synthase kinase - 3β and CDK5/p25, two kinases involved in abnormal tau phosphorylation in Alzheimer's disease - a property common to most CDK inhibitors? J. Biol. Chem. 276 2001 251 260 (Pubitemid 32050314)
11. Y.H. Lee, J.D. Park, N.I. Beak, S.I. Kim, and B.Z. Ahn In vitro and in vivo antitumoral phenanthrenes from the aerial parts of Dendrobium nobile Planta Med. 61 1995 178 180
12. R.M. Letcher, and L.R.M. Nhamo Chemical constituents of the Combretaceae. Part III. Substituted phenanthrenes, 9,10-dihydro-phenanthrenes, and bibenzyls from the heartwood of Combretum psidioides J. Chem. Soc., Perkin Trans. I. 23 1972 2941 2946
13. P. Majumder, S. Laha, and N. Datta Coelonin, a 9,10-dihydrophenanthrene from the orchids Coelogyne ochracea and Coelogyne elata Phytochemistry 21 1982 478 480
14. M. Malumbres, and M. Barbacid Cell cycle CDKs and cancer: a changing paradigm Nat. Rev. Cancer 9 2009 153 166
15. M. Malumbres, P. Pevarello, M. Barbacid, and J.R. Bischoff CDK inhibitors in cancer therapy: what is next? Trends Pharmacol. Sci. 29 2008 16 21
16. M. Malumbres, E. Harlow, T. Hunt, T. Hunter, J.M. Lahti, and G. Manning Cyclin-dependent kinases: a family portrait Nat. Cell Biol. 11 2009 1275 1276
17. B. Réthy, A. Kovács, I. Zupkó, P. Forgo, A. Vasas, G. Falkay, and J. Hohmann Cytotoxic phenanthrenes from the rhizomes of Tamanus communis Planta Med. 72 2006 767 770 (Pubitemid 44073465)
18. G.I. Shapiro Cyclin-dependent kinase pathways as targets for cancer treatment J. Clin. Oncol. 24 2006 1770 1783 (Pubitemid 46628473)
19. P.J. Smith, and E. Yue CDK Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents. Monographs on Enzyme Inhibitors 2006 CRC Press, Taylor & Francis Boca Raton, FL
20. C. Tempête, G.H. Werner, F. Favre, A. Rojas, and N. Langlois In vitro cytostatic activity of 9-demethoxyporothramycin B Eur. J. Med. Chem. 30 1995 647 650
21. K. Vermeulen, D.R. Van Bockstaele, and Z.N. Berneman The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer Cell Prolif. 36 2003 131 149 (Pubitemid 36808270)
22. Z. Xue, S. Li, S. Wang, Y. Wang, Y. Yang, J. Shi, and L. He Mono-, bi-, and triphenanthrenes from the tubers of Cremastra appendiculata J. Nat. Prod. 69 2006 907 913 (Pubitemid 44166264)
23. M. Yamaki, L. Bai, T. Kato, K. Inoue, S. Takagi, Y. Yamagata, and K.-I. Tomita Bisphenanthrene ethers from Bletilla striata Phytochemistry 31 1992 3985 3987
24. K. Yoshikawa, T. Ito, K. Iseki, C. Baba, H. Imagawa, Y. Yagi, H. Morita, Y. Asakawa, S. Kawano, and T. Hashimoto Phenanthrene derivatives from Cymbidium great flower Marie laurencin and their biological activities J. Nat. Prod. 2012 10.1021/np200788u